• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓素A2在大鼠内耳微循环障碍中的作用。

Role of thromboxane A2 in a microcirculation disorder of the rat inner ear.

作者信息

Umemura K, Asai Y, Uematsu T, Nakashima M

机构信息

Department of Pharmacology, Hamamatsu University School of Medicine, Japan.

出版信息

Eur Arch Otorhinolaryngol. 1993;250(6):342-4. doi: 10.1007/BF00188383.

DOI:10.1007/BF00188383
PMID:8260145
Abstract

Since thromboxane (TX) A2 causes vasoconstriction and platelet aggregation, we evaluation the effect of a TXA2 receptor antagonist (vapiprost) and a TXA2 synthetase inhibitor (Y-20811) on a microcirculation disorder in the rat inner ear that was induced by a photochemical reaction between an intravenous injection of rose bengal (RB) and green light. A gradual decrease of the cochlear action potential (CAP) to an 8 kHz sound stimulus was measured with an electrocochleogram and occurred after the RB injection. The CAP then disappeared 5 min after the injection of RB. Both vapiprost and Y-20811 significantly prolonged the time required to complete suppression of the CAP as compared with saline as control. These findings indicate that TXA2 may play an important role in microcirculation disorders in the rat inner ear.

摘要

由于血栓素(TX)A2会引起血管收缩和血小板聚集,我们评估了TX A2受体拮抗剂(前列环醇)和TX A2合成酶抑制剂(Y - 20811)对大鼠内耳微循环障碍的影响,该微循环障碍是由静脉注射孟加拉玫瑰红(RB)与绿光之间的光化学反应诱导产生的。用电耳蜗图测量了对8 kHz声音刺激的耳蜗动作电位(CAP)的逐渐下降情况,其在RB注射后出现。然后,CAP在RB注射后5分钟消失。与作为对照的生理盐水相比,前列环醇和Y - 20811均显著延长了完全抑制CAP所需的时间。这些发现表明,TX A2可能在大鼠内耳微循环障碍中起重要作用。

相似文献

1
Role of thromboxane A2 in a microcirculation disorder of the rat inner ear.血栓素A2在大鼠内耳微循环障碍中的作用。
Eur Arch Otorhinolaryngol. 1993;250(6):342-4. doi: 10.1007/BF00188383.
2
Comparison of the inhibitory effects of the TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2.血栓素A2受体拮抗剂瓦吡前列素与其他抗血小板药物对大鼠动脉血栓形成抑制作用的比较:血栓素A2的可能作用
Thromb Haemost. 1992 Oct 5;68(4):460-3.
3
The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.新型血栓素A2受体拮抗剂瓦匹前列素对人血小板二次聚集和ATP释放的强效抑制作用。
Biol Pharm Bull. 1997 Jun;20(6):625-31. doi: 10.1248/bpb.20.625.
4
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.血栓素(Tx)A2受体阻断与TxA2合酶抑制单独及联合应用:对人血小板抗聚集疗效的比较
Br J Pharmacol. 1991 Feb;102(2):497-505. doi: 10.1111/j.1476-5381.1991.tb12200.x.
5
DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.DTTX30是一种血栓素受体拮抗剂和血栓素合成酶抑制剂的组合,可预防麻醉犬的冠状动脉血栓形成。
Basic Res Cardiol. 1997 Jun;92(3):181-90. doi: 10.1007/BF00788635.
6
Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig.血小板活化因子、血栓素A2、二磷酸腺苷及凝血酶在豚鼠血栓形成中的作用
Eur J Pharmacol. 1993 Feb 16;231(3):421-5. doi: 10.1016/0014-2999(93)90119-3.
7
Effect of ibudilast on microcirculation thrombosis in rat inner ear.异丁司特对大鼠内耳微循环血栓形成的影响。
Jpn J Pharmacol. 1993 Feb;61(2):75-9. doi: 10.1254/jjp.61.75.
8
Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.肉桂亲和素的药理学特性研究,一种新型血栓素合酶和血栓素A2受体双重抑制剂。
Br J Pharmacol. 1994 Mar;111(3):906-12. doi: 10.1111/j.1476-5381.1994.tb14824.x.
9
Inhibitory effect of clopidogrel, vapiprost and argatroban on the middle cerebral artery thrombosis in the rat.氯吡格雷、前列环素和阿加曲班对大鼠大脑中动脉血栓形成的抑制作用。
Jpn J Pharmacol. 1995 Mar;67(3):253-8. doi: 10.1254/jjp.67.253.
10
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:603-6.

引用本文的文献

1
An Antioxidant Screen Identifies Candidates for Protection of Cochlear Hair Cells from Gentamicin Toxicity.抗氧化剂筛选确定了保护耳蜗毛细胞免受庆大霉素毒性影响的候选物质。
Front Cell Neurosci. 2017 Aug 18;11:242. doi: 10.3389/fncel.2017.00242. eCollection 2017.
2
Effects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection.非甾体抗炎药对内耳的影响:可能参与耳蜗保护。
Pharmaceuticals (Basel). 2010 Apr 27;3(5):1286-1295. doi: 10.3390/ph3051286.

本文引用的文献

1
Postural vertigo due to unilateral sudden partial loss of vestibular function.单侧前庭功能突然部分丧失所致的姿势性眩晕。
Ann Otol Rhinol Laryngol. 1956 Sep;65(3):692-706. doi: 10.1177/000348945606500311.
2
Sudden deafness and vertigo due to inner ear hemorrhage--a temporal bone case report.内耳出血导致的突发性耳聋和眩晕——一例颞骨病例报告。
J Otolaryngol. 1984 Aug;13(4):201-7.
3
Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.前列腺素内过氧化物在血小板与内皮细胞之间的单向转运。
J Clin Invest. 1984 Apr;73(4):1105-12. doi: 10.1172/JCI111296.
4
Vascular changes in the human inner ear associated with aging.
Ann Otol Rhinol Laryngol. 1972 Jun;81(3):364-76. doi: 10.1177/000348947208100307.
5
Prostaglandin synthesis by the cochlea of the guinea pig. Influence of aspirin, gentamicin, and acoustic stimulation.豚鼠耳蜗中前列腺素的合成。阿司匹林、庆大霉素及声刺激的影响。
Prostaglandins. 1985 Apr;29(4):589-99. doi: 10.1016/0090-6980(85)90082-6.
6
Otolaryngological problems associated with thrombocytopenia purpura in children.儿童血小板减少性紫癜相关的耳鼻喉科问题
Int J Pediatr Otorhinolaryngol. 1988 Feb;15(1):87-92. doi: 10.1016/0165-5876(88)90054-7.
7
Perspectives in platelet-activating factor research.血小板活化因子研究的展望
Pharmacol Rev. 1987 Jun;39(2):97-145.
8
Blood viscosity as a factor in sensorineural hearing impairment.血液粘度作为感音神经性听力损失的一个因素。
Lancet. 1986 Jan 18;1(8473):121-3. doi: 10.1016/s0140-6736(86)92261-0.
9
Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by oral administration.新型长效血栓素合成酶抑制剂Y-20811口服给药的I期研究
J Clin Pharmacol. 1989 Jun;29(6):568-76. doi: 10.1002/j.1552-4604.1989.tb03384.x.
10
The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.血栓素受体阻断药物GR32191对人血小板聚集、黏附和分泌的抑制作用。
Thromb Haemost. 1989 Jun 30;61(3):429-36.